SCOTUS okays Medtronic's $112 million loss in patent contract case

The U.S. Supreme Court on Monday declined a request by medical-device maker Medtronic Inc to review a case involving surgical-screw patents, letting stand a $112 million verdict against the company for breaching a royalty agreement.

Medtronic’s IP dispute against Axonics could resume in court after PTAB decisions

Medtronic (NYSE:MDT) and Axonics (NSDQ:AXNX) could see their patent dispute over neurostimulation technology resume in court. Yesterday, the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office affirmed an additional three...